Genticel raises EUR 18.2 million

Vaccine company Genticel S.A. (Labege, France) raised EUR 18.2 million ($23.8 million) in a series C round led by new investor Wellington Partners. Existing investors Idinvest Partners; Edmond de Rothschild Investment Partners; InnoBio Fund; Institut Regional de Developpement Industriel; and Amundi Private Equity Funds also participated. Wellington Partners' Rainer Strohmenger will join Genticel's board. ...